文献速递乳房整形与再造创面修复

乳房切除皮瓣坏死对胸肌前重建结局的影响

Impact of mastectomy flap necrosis on prepectoral reconstructive outcomes.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-02-02

该单中心回顾性研究纳入301例患者共509侧即刻两阶段胸肌前乳房重建,至少随访3个月。44例(14.6%)发生乳房切除皮瓣坏死。坏死组组织扩张器后再次手术率(64% vs 19%,p<0.01)和扩张器更换率(13.6% vs 3.5%,p=0.02)更高,但重建失败率、感染率及最终假体植入后并发症率无显著差异。

要点

  • 胸肌前乳房重建中乳房切除皮瓣坏死发生率为14.6%(44/301例)。
  • 皮瓣坏死组组织扩张器后再次手术率64% vs 无坏死组19%(p<0.01)。
  • 皮瓣坏死组扩张器更换率13.6% vs 无坏死组3.5%(p=0.02)。

核心结论

  • 乳房切除皮瓣坏死是胸肌前假体乳房重建术后值得关注的事件。
  • 皮瓣坏死患者组织扩张器阶段再次手术率更高,但感染率和最终重建结局与无坏死患者相似。

研究设计与样本

  • 单中心回顾性研究,纳入接受即刻两阶段胸肌前乳房重建且随访至少3个月的患者。
  • 共301例患者、509侧胸肌前乳房重建。
  • 比较有无乳房切除皮瓣坏死患者的术后并发症、重建结局及至最终假体植入时间。

主要发现

  • 44例患者(14.6%)发生术后乳房切除皮瓣坏死。
  • 坏死组与无坏死组的人口学和重建特征相似。
  • 坏死组组织扩张器后再次手术率64% vs 无坏死组19%(p<0.01),扩张器更换率13.6% vs 3.5%(p=0.02)。
  • 两组重建失败率(6.8% vs 6.2%)、主要感染率(9.1% vs 9.0%)、次要感染率(13.6% vs 17.5%)在扩张器置入后统计学相似。
  • 坏死组至最终假体植入时间有延长趋势但无统计学显著差异(6.5 vs 5.0个月,p=0.08);最终假体植入后并发症率无差异,但坏死组假体植入后修整手术率更高(12.5% vs 4.1%,p=0.047)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: As reconstructive surgeons have increasingly transitioned to the prepectoral plane for prosthetic breast reconstruction, the implications of mastectomy skin flap necrosis have become more concerning. Our goal was to evaluate the effect of skin flap necrosis on reconstructive outcomes in patients undergoing immediate prepectoral breast reconstruction. METHODS: A retrospective review was conducted of patients undergoing immediate two-stage prepectoral reconstruction at a single center with at least 3 months follow-up. Postoperative complications, reconstructive outcome, and time to final implant were compared between patients with and without mastectomy skin necrosis. RESULTS: A total of 301 patients underwent 509 prepectoral breast reconstructions. Forty-four patients (14.6%) experienced postoperative mastectomy skin flap necrosis. Demographic and reconstructive characteristics were similar between the necrosis and no necrosis cohorts. Patients with skin necrosis were more likely to undergo reoperation after tissue expander (64% vs 19%, p < 0.01) and undergo expander replacement (13.6% vs 3.5%, p = 0.02). However, rates of reconstructive failure (6.8% vs 6.2%), major infection (9.1% vs 9.0%), and minor infection (13.6% vs 17.5%) after expander placement were statistically similar. Patients with skin necrosis trended toward longer time before final implant placement, although the difference was not statistically significant (6.5 vs 5.0 months, p = 0.08). There was no difference in complication rates between the necrosis and no necrosis cohort after final implant placement. There was a higher rate of revision surgery after implant placement in the necrosis cohort (12.5% vs 4.1%, p = 0.047). CONCLUSIONS: Mastectomy skin flap necrosis is a concerning postoperative event, particularly in patients with prepectoral prostheses. We observed that patients with skin necrosis experience higher reoperation rates in the expander period, yet have similar infection rates and achieve similar final reconstructive outcomes compared to patients without necrosis.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Musavi L, Bingham EG, Anderson L, et al. Impact of mastectomy flap necrosis on prepectoral reconstructive outcomes. J Plast Reconstr Aesthet Surg. 2024. PMID: 38417391. doi:10.1016/j.bjps.2024.01.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。